DelveInsight’s ‘Post-Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast 2032’ report deliver an in-depth understanding of Post-Traumatic Stress Disorder, historical and forecasted epidemiology as well as the market trends in the United States, EU4(Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Post-Traumatic Stress Disorder market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted Post-Traumatic Stress Disorder symptoms market size from 2019 to 2032 segmented by seven major markets. The report also covers current Post-Traumatic Stress Disorder symptoms, treatment practices/algorithms and unmet medical needs to curate the best opportunities. It assesses the underlying potential of the market.
Key Points of Post-Traumatic Stress Disorder Market
-
Among EU5 countries, Germany had the highest number of prevalent cases of Post-Traumatic Stress Disorder (more than 7,000,00 cases) in 2021.
-
Spain had the lowest prevalent population of Post-Traumatic Stress Disorder (around 3,890,000 cases) in 2021.
Key Benefits of the Post-Traumatic Stress Disorder Market Report
-
The report covers the descriptive overview of Hypoxia, explaining its causes, signs, and symptoms, pathophysiology, diagnosis, and currently available therapies
-
Comprehensive insight have been provided into the Hypoxia epidemiology and treatment in the 7MM
-
Additionally, an all-inclusive account of both the current and emerging therapies for Hypoxia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
-
A detailed review of the Hypoxia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
-
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hypoxia market
Got queries? Click here to know more about the Post-Traumatic Stress Disorder Market Landscape
Post-Traumatic Stress Disorder Overview
Post-traumatic stress disorder (PTSD) has been described as “the complex somatic, cognitive, affective, and behavioral effects of psychological trauma.” It is characterized by intrusive thoughts, nightmares, and flashbacks of past traumatic events, avoidance of reminders of trauma, hypervigilance, and sleep disturbance, all of which lead to considerable social, occupational, and interpersonal dysfunction. PTSD symptoms may start within 1 month of a traumatic event, but sometimes symptoms may not appear until years after the event.
These symptoms cause significant problems in social or work situations and relationships. They can also interfere with the ability to go about the normal daily tasks, and the symptoms are generally grouped into four types: intrusive memories, avoidance, negative changes in thinking and mood, and changes in physical and emotional reactions. Symptoms can vary over time or vary from person to person. Patients can develop PTSD when they go through, see or learn about an event involving actual or threatened death, serious injury, or sexual violation.
Post-Traumatic Stress Disorder Epidemiological Insight
-
In the year 2021, the prevalence population cases of PTSD were 13,538.4 thousand (K) cases in the 7MM, which might rise to reach 14,912.0 K cases by 2032 at a CAGR of 0.9%. In the 7MM, the highest number of prevalent cases of PTSD was observed in the US.
-
In EU4 and the UK countries the prevalent population cases of PTSD were 3,347.1 K cases in the year 2021, which is estimated to rise and reach 3,573.9 K cases by the year 2032 at a CAGR of 0.6%.
-
In the year 2021, the diagnosed prevalent cases of PTSD were 5,341.0 K cases in the 7MM, which might rise to reach 7,006.3 K cases, respectively, by 2032.
-
In the year 2021, the gender-specific cases of PTSD were 4,120.3 K cases male and 9,418.1 K cases for female respectively, in the 7MM, which might rise to reach 4,552.2 K and 10,359.9 K cases, respectively, by 2032.
-
In the year 2021, the severity-specific cases of PTSD were 1,692.0 K cases for mild, 1,707.2 K cases for moderate and 1,941.8 K cases for severe respectively, in the 7MM, which might rise to reach 2,209.9 K, 2,246.9 K and 2,549.5 K cases, respectively, by 2032.
-
In the year 2021, the total treated cases of PTSD were 2,490.5 K cases respectively, in the 7MM, which might increase to 3,784.6 K cases respectively, by 2032.
Post-Traumatic Stress Disorder Epidemiological Segmentation
-
Prevalence population of Post Traumatic Stress Disorder
-
Diagnosed prevalent Cases of Post Traumatic Stress Disorder
-
Gender-specific Cases of Post Traumatic Stress Disorder
-
Age-specific Cases of Post Traumatic Stress Disorder
-
Diagnosed prevalent Cases of Post Traumatic Stress Disoder
-
Severity-specific Cases of Post Traumatic Stress Disorder
-
Total Treated cases of Post Traumatic Stress Disorder
Post-Traumatic Stress Disorder Market Outlook
The Post-Traumatic Stress Disorder (PTSD) market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Post-Traumatic Stress Disorder (PTSD) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand of better technology.
This segment gives a thorough detail of Post-Traumatic Stress Disorder (PTSD) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Post-Traumatic Stress Disorder (PTSD) market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Post-Traumatic Stress Disorder Market Landscape
Post-Traumatic Stress Disorder Key Companies
-
Otsuka Pharmaceutical
-
Aptinyx
-
Jazz Pharmaceutical
-
Bionomics Limited
-
And many more
Post-Traumatic Stress Disorder Key Therapies
-
Rexulti (brexpiprazole) and Zoloft (sertraline) combination
-
NYX-783
-
JZP150
-
BNC210
-
And many more
Table of Contents
-
Key Insights
-
Report Introduction
-
Executive Summary of Post-Traumatic Stress Disorder Market
-
Disease Background and Overview
-
Epidemiology and patient population
-
The United States
-
EU 5
-
Post-Traumatic Stress Disorder Market Emerging Therapies
-
Post-Traumatic Stress Disorder Market Outlook
-
Market Drivers
-
Market Barriers
-
Market Access and Reimbursement of Therapies
-
Appendix
-
Post-Traumatic Stress Disorder Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
-
About DelveInsight
Click here to read more about Post-Traumatic Stress Disorder Market Landscape
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services